Kairos Pharma KAPA Q4 2024 earnings
Reported February 26, 2025 · Before market open
EPS estimate-$0.06
Next report
Aug 11, 2026 (In 4 weeks)EPS estimate-$0.09
Versus estimates
Diluted EPS
Ask the moment Kairos Pharma reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Kairos Pharma report Q4 2024 earnings?
- Kairos Pharma (KAPA) reported Q4 2024 earnings on February 26, 2025 before market open.
- What were Kairos Pharma's Q4 2024 revenue and EPS?
- Kairos Pharma reported diluted EPS of $-0.09 for Q4 2024.
- Did Kairos Pharma beat estimates in Q4 2024?
- EPS missed the consensus estimate of $-0.06 by $0.03.